Dyne Therapeutics, Inc. (DYN)

Healthcare · Biotechnology · NASDAQ

Dyne Therapeutics, Inc. (DYN) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $3.20B and a free-cash-flow yield of -19.2%.

Market cap	$3.20B
Trailing P/E	—
FCF yield	-19.2%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live DYN data on Nama Insights →